Litigation Details for Sanofi-Aventis U.S. LLC v. Mylan Laboratories Limited (D. Del. 2020)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Mylan Laboratories Limited (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-06-05 |
Court | District Court, D. Delaware | Date Terminated | 2021-09-08 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,583,110 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Mylan Laboratories Limited
Details for Sanofi-Aventis U.S. LLC v. Mylan Laboratories Limited (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-09-08 | 23 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2; 10,716,777 B2.… 8 September 2021 1:20-cv-00761 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |